2 assets in Acute Respiratory Distress Syndrome

Therapeutic assets addressing Acute Respiratory Distress Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Recombinant Human Keratinocyte Growth Factor-2 For Inhalation Acute Respiratory Distress Syndrome	Shanghai Zhongshan Hospital	Early P1	C (39)
Oxygen Acute Respiratory Distress Syndrome	Evangelismos Hospital	N/A	D (30)